ArrowMark Colorado Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

ArrowMark Colorado Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.7M	Sell	62,441 -20,183	-24%	-$9.64M	0.87%	36
2025 Q4	$48.1M	Sell	82,624 -40,635	-33%	-$20.8M	1.06%	28
2025 Q3	$56.5M	Sell	123,259 -21,549	-15%	-$8.04M	1.05%	32
2025 Q2	$43.8M	Sell	144,808 -35,301	-20%	-$10.5M	0.79%	43
2025 Q1	$59.7M	Sell	180,109 -19,558	-10%	-$6.43M	0.97%	35
2024 Q4	$61.6M	Buy	199,667 +37,715	+23%	+$10.6M	0.83%	39
2024 Q3	$34.4M	Sell	161,952 -25,441	-14%	-$6.51M	0.44%	67
2024 Q2	$52.5M	Buy	187,393 +153,174	+448%	+$36.5M	0.63%	46
2024 Q1	$9.14M	Buy	+34,219	New	+$8.06M	0.1%	156

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ArrowMark Colorado Holdings's MDGL Position: Q1 2026 in Review

ArrowMark Colorado Holdings reduced its Madrigal Pharmaceuticals (MDGL) stake by 24% in Q1 2026, selling an estimated $9.64M and leaving 62,441 shares worth $32.7M. The position accounts for 0.87% of the portfolio, ranked #36.

ArrowMark Colorado Holdings first reported a position in MDGL in Q1 2024 and has held it in 9 quarters since. The position peaked at $61.6M in Q4 2024. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

ArrowMark Colorado Holdings held 62,441 shares of Madrigal Pharmaceuticals worth $32.7M as of Q1 2026.
ArrowMark Colorado Holdings sold 20,183 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $9.64M.
Madrigal Pharmaceuticals made up 0.87% of ArrowMark Colorado Holdings's portfolio in Q1 2026, its #36 holding.
ArrowMark Colorado Holdings first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
ArrowMark Colorado Holdings's Madrigal Pharmaceuticals position peaked at $61.6M in Q4 2024.
378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.